Improvement of Obsessive-compulsive Disorder with Divalproex and Lamotrigine in Two Patients with Bipolar II Disorder
The DOI matches its Crossref record.
Abstract
We describe two cases of patients with bipolar II disorder and comorbid obsessive-compulsive disorder who received treatment with mood stabilizers (lamotrigine and divalproex). The patients reported significant improvements of both conditions. Divalproex (DVP) and lamotrigine (LMT) have been used as mood stabilizers for the treatment and the prevention of recurrence of bipolar disorder. The first is recommended for treatment of acute mania and maintenance treatment of bipolar disorder (BD) and the latter is useful for prevention of bipolar depressive episodes. The lifetime prevalence of bipolar spectrum disorders is 4.4–6.5% of the general population [ 1 ] [ 12 ]. Comorbidity of obsessive compulsive disorder (OCD) was found in 10–25% of bipolar I and II patients [ 12 ] [ 14 ], with a negative impact on the course and treatment of BD [ 12 ]. The treatment of patients with both conditions (BD and OCD) is a therapeutic dilemma because effective treatments of OCD, such as high-dose serotonin reuptake inhibitors (SRIs), could cause switching to mania and rapid cycling [ 11 ]. Furthermore, the clinical trials that have led to the approval of SRIs for the treatment of OCD exclude patients with bipolar disorder as a rule. Atypical antipsychotics, which are effective for the treatment of bipolar disorder, have emerged as a therapeutic alternative in refractory OCD, but can be associated with significant side-effects and limited efficacy [ 3 ] [ 6 ]. There are no controlled trials for comorbidities; thus, therapeutic options with minor risks have high clinical relevance in this population. Regarding anticonvulsants, there is a report on 8 refractory OCD patients treated with lamotrigine as add-on to SRIs, with 1 responder [ 8 ], another report of improvement with valproate monotherapy in one patient with OCD [ 4 ] and another report of improvement of treatment-resistant obsessive-compulsive disorder (OCD) with a pharmacological augmentation of topiramate plus paroxetine [ 7 ]. Zink et al. [ 16 ] (2007) described one patient with schizophrenia who developed obsessive-compulsive symptoms after clozapine was initiated and improved with valproic acid. We describe two cases of patients with the diagnoses of BD and OCD who presented with improvements of mood and anxiety symptoms under mood-stabilizers only. A 36-year-old white woman with previous diagnoses of panic disorder (PD) and recurrent depressive episodes had undergone treatment with antidepressants since 18 years of age, with partial response. Diagnostic evaluation revealed that she later developed episodes of irritable mood, overactivity, racing thoughts, pressure of speech, decrease need for sleep, paranoid symptoms, buying sprees and anger attacks that lasted up to one month, alternating with depressive episodes, therefore fulfilling the DSM-IV diagnostic criteria for bipolar II disorder. She had obsessive-compulsive disorder since 10 years of age, especially with fear of contamination, repetitive behaviours of excessive cleaning and checking door locks. Under treatment with fluoxetine 20 mg her mood was unstable, with no impact on OCD symptoms. She started treatment with lamotrigine up to 100 mg/d with a significant improvement of depressive symptoms, irritability and obsessive-compulsive symptoms. However, panic symptoms increased and paroxetine up to 20 mg was added, triggering a hypomanic episode. Paroxetine was discontinued and divalproex up to 500 mg/d was started. Currently, the patient is on treatment with lamotrigine 100 mg/d and divalproex 500 mg/d with improvement of BD, OCD and panic disorder. Her score on the Yale-Brown Obsessive-Compulsive Scale (YBOCS) decreased from 46 prior to treatment to 04 after six months. She remained stable for two years. A 31-year-old white man had bipolar II disorder, with anger attacks, overactivity, racing thoughts in hypomanic episodes that lasted up to one week and alternated with episodes of atypical depression. He has a family history of BD and reported a switch to mania with venlafaxine in the past. He met the DSM-IV criteria for alcohol abuse and OCD. He had obsessive-compulsive symptoms since 15 years of age and mood symptoms since 26 years of age. The most prominent symptoms of OCD were repetitive behaviour of checking door locks, electrical outlets and hoarding. He was referred to psychiatric evaluation by his psychologist who had been conducting cognitive-behavioural psychotherapy for one year without good response. Treatment with divalproex up to 1 000 mg/d was initiated and after six weeks the patient reported a significant improvement of alcohol abuse and obsessive-compulsive symptoms. His YBOCS score declined from 23 prior to treatment to 04. He stopped the mood stabilizer and the symptoms returned, but after the reintroduction of medication he improved again. He has been symptom-free for 18 months. In agreement with comorbidity studies, some authors have proposed a distinction between bipolar/cyclothymic
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The CANMAT Task Force 2012 report included several small case reports indicating the potential benefit of lithium,743 anticonvulsants,743, 746 olanzapine,747, 748 risperidone,749, 750 quetiapine751 and aripiprazole 752 for the treatment of comorbid OCD (all level 4 evidence).”
Citations
Cites
Still being checked.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Amerio, A., Odone, A., Liapis, C. C., & Ghaemi, S. N. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12250 · Cited by 109
Treatment of comorbid bipolar disorder and obsessive–compulsive disorder: A systematic review
Amerio, A., Odone, A., Marchesi, C., & Ghaemi, S. N. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.026 · Cited by 71
Glutamatergic augmentation strategies in obsessive–compulsive disorder
Narayanaswamy, J., & Sheshachala, K. (2019) · Indian Journal of Psychiatry · doi:10.4103/psychiatry.indianjpsychiatry_520_18 · Cited by 30
Arrojo, M., Alonso, M. T., & de León, J. (2013) · Case Reports in Psychiatry · doi:10.1155/2013/612459 · Cited by 22
Metadata
- Authors
- Bisol, L., & Lara, D.
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2009-01
- Volume
- 42
- Issue
- 01
- Pages
- 37-39
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2056409135
- Cited by
- 19
- References
- 0
- Citations by year
- 2026: 1 · 2024: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 4 · 2015: 3 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar II disorder, obsessive-compulsive disorder, comorbidities, divalproex, lamotrigine, mood stabilizers, valproic acid, antiepileptic drugs, treatment-resistant OCD, bipolar depression, panic disorder, topiramate, paroxetine, rapid cycling bipolar disorder, mania, serotonin reuptake inhibitors
- MeSH terms
- Lamotrigine, Adult, Anticonvulsants, Bipolar Disorder, Female, Humans, Male, Obsessive-Compulsive Disorder, Triazines, Valproic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Improvement of Obsessive-compulsive Disorder with Divalproex and Lamotrigine in Two Patients with Bipolar II Disorder. https://app.cochat.ai/papers/10.1055/s-0028-1085439
- The paper
- Bisol, L., & Lara, D. (2009). Improvement of Obsessive-compulsive Disorder with Divalproex and Lamotrigine in Two Patients with Bipolar II Disorder. Pharmacopsychiatry. https://doi.org/10.1055/s-0028-1085439
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.